Dashboard
Poor Management Efficiency with a low ROCE of 6.38%
- The company has been able to generate a Return on Capital Employed (avg) of 6.38% signifying low profitability per unit of total capital (equity and debt)
- OPERATING CASH FLOW(Y) Lowest at USD 283 MM
- ROCE(HY) Lowest at -37.78%
- DEBT-EQUITY RATIO (HY) Highest at 108.93 %
Risky -
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Pharmaceuticals & Biotechnology
USD 3,487 Million (Small Cap)
22.00
NA
196.12%
1.04
17.95%
1.78
Total Returns (Price + Dividend) 
Dentsply Sirona, Inc. for the last several years.
Risk Adjusted Returns v/s 
News

Dentsply Sirona Hits Day Low of $10.69 Amid Price Pressure
Dentsply Sirona, Inc. faced notable volatility, with its stock declining significantly today. The company has struggled with consistent underperformance over various timeframes, including a year-to-date loss of 41.94%. Despite some positive indicators, challenges such as low management efficiency and high institutional holdings contribute to a risky trading environment.
Read More
Dentsply Sirona Faces Weak Start with 9% Gap Down Amid Market Concerns
Dentsply Sirona, Inc. has experienced a significant decline in stock performance, with notable losses over the past day and month. Technical indicators suggest a bearish sentiment, while the company maintains a market capitalization of approximately USD 3.487 billion and a high dividend yield, despite a challenging financial environment.
Read More
Dentsply Sirona Hits 52-Week Low at $10.69 Amidst Significant Decline
Dentsply Sirona, Inc. has reached a new 52-week low, reflecting a substantial decline over the past year. The company, with a market capitalization of USD 3,487 million, faces profitability challenges despite a high dividend yield and positive operating profit margins. Its stock shows significant volatility and institutional ownership.
Read More Announcements 
Corporate Actions 
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2025
Shareholding Compare (%holding) 
Domestic Funds
Held in 106 Schemes (73.7%)
Held by 250 Foreign Institutions (18.21%)
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
QoQ Growth in quarter ended Jun 2025 is 6.48% vs -2.87% in Mar 2025
QoQ Growth in quarter ended Jun 2025 is -331.58% vs 104.44% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is -4.34% vs 1.10% in Dec 2023
YoY Growth in year ended Dec 2024 is -589.39% vs 86.11% in Dec 2023






